News

Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...
A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant ...
Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.
Natco Pharma CEO discusses impact of U.S. tariffs on Indian pharma industry and strategies for diversification and growth.
Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...
Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...
The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...
Directed by PR Arun, the series explores the ethical complexities of India's pharmaceutical industry through the journey of a ...
An update from Piramal Pharma Limited ( ($IN:PPLPHARMA) ) is now available. Piramal Pharma Limited announced the completion of a significant ...
India seeks to significantly boost its medicine exports to Mexico, a market currently valued at over $20 billion and expected ...